Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COMPREHENSIVE COMPLIANCE REVIEWS PLANNED FOR THREE TO FOUR DEVICE CATEGORIES IN 1997 UNDER FDA "RISK-BASED" SURVEILLANCE INITIATIVE; PUBLIC MEETING PLANNED

This article was originally published in The Gray Sheet

Executive Summary

FDA is targeting three to four devices for intensive compliance scrutiny in the coming year out of a list of 15 devices designated as high priorities for action. The list was unveiled by Lillian Gill, director of the Office of Compliance in FDA's Center for Devices and Radiological Health, Dec. 10 at the Food and Drug Law Institute annual conference on Dec. 10 in Washington, D.C.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007246

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel